Sanofi Stuns Investors as U.S. Price Pressure Bites

By Hester Plumridge

Sanofi CEO Christopher A. Viehbacher pictured in May.
Agence France-Presse/Getty Images

Sanofi SA became the second European drug maker to be hit by cold winds from across the Atlantic Tuesday, as pharmaceutical companies reel from price squeezes in the U.S., their most profitable market.

Shares in Sanofi fell 8% …read more

Source:: MoneyBeat